期刊文献+

腹腔镜与同期开腹直肠癌切除术后长期肿瘤学结果的对比研究 被引量:32

Comparison of long-term oncological outcomes of laparoscopic and open resection of rectal cancer
下载PDF
导出
摘要 目的比较腹腔镜及同期开腹直肠癌切除术术后的长期肿瘤学结果。方法回顾性分析南方医院自2003年1月~2008年12月收治的514例病人的临床随访资料,对186例腹腔镜组和328例开腹组病人术后复发类型及长期生存结果进行了比较。结果两组病人的中位随访时间为(48.54±28.76)月,两组间远处转移(3.9%vs 5.5%;P=0.284)、5年累积总生存率(69.5%vs 61.7%;P=0.085)和5年无病生存率(67.7%vs 60.7%;P=0.110)的差异无统计学意义。IV期病例中腹腔镜组5年累计总生存率和5年无进展生存率均高于开腹组(P〈0.05)。结论腹腔镜直肠癌切除术可以获得不劣于开腹手术的长期肿瘤学结果。 Objective To compare the long-term oncological outcomes of laparoscopic and open resection of rectal cancers.Methods Between January,2003 and December,2008,514 patients with rectal cancer were admitted in our hospital,among whom 186 underwent laparoscopic tumor resection and 238 received open radical resection of the tumors.The long-term survival of the patients and the recurrence pattern were compared between the two groups.Results The median follow-up of the patients was 48.54±28.76 months.No significant differences were found between the two groups in the local recurrence rate(3.9% vs 5.5%,P=0.284),5-year overall survival(69.4% vs 61.3%,P=0.067),or the 5-year disease-free survival rates(67.7% vs 60.7%,P=0.110).Both the 5-year overall survival and progression-free survival of the patients in stage IV were better in the laparoscopic group than in the open surgery group(P0.05).Conclusion Laparoscopic resection of rectal cancer can achieve long-term oncological outcomes comparable to those of conventional open surgery.
出处 《南方医科大学学报》 CAS CSCD 北大核心 2012年第5期664-668,共5页 Journal of Southern Medical University
基金 广东省自然科学基金(07300474) 广州科技计划项目(2008A030201017)
关键词 直肠癌 腹腔镜手术 开腹手术 rectal cancer laparoscopic resection open resection
  • 相关文献

参考文献21

  • 1Ohtani H,Tamamori Y,Azuma T,et al.A meta-analysis of the short-and long-term results of randomized controlled trials that comparedlaparoscopy-assisted and conventional open surgery for rectalcance[r J].J Gastrointest Surg,2011,15(8):1375-85.
  • 2黄美近,彭慧,王辉,梁景琳,饶本强,康亮,张兴伟,汪建平.直肠癌腹腔镜与开腹手术肿瘤清除及远期疗效的随机对照试验荟萃分析[J].中华胃肠外科杂志,2011,14(8):606-610. 被引量:30
  • 3Anderson C,Uman G,Pigazzi A.Oncologic outcomes of laparo-scopic surgery for rectal cancer:a systematic review andmeta-analysis of the literature[J].Eur J Surg Oncol,2008,34(10):1135-42.
  • 4da Luz Moreira A,Mor I,Geisler DP,et al.Laparoscopic resectionfor rectal cancer:a case-matched study[J].Surg Endosc,2011,25(1):278-83.
  • 5Baik SH,Gincherman M,Mutch MG,et al.Laparoscopic vs openresection for patients with rectal cancer:comparison ofperioperative outcomes and long-term survival[J].Dis ColonRectum,2011,54(1):6-14.
  • 6梁耀泽,余江,张策,王亚楠,程侠,黄枫,李国新.基于临床数据挖掘技术的腹腔镜结直肠癌手术评估体系的构建及应用[J].中华胃肠外科杂志,2010,13(10):741-744. 被引量:11
  • 7Guillou PJ,Quirke P,Thorpe H,et al.Short-term endpoints ofconventional versus laparoscopic-assisted surgery in patients withcolorectal cancer(MRC CLASICC trial):multicentre,randomisedcontrolled tria[l J].Lancet,2005,365(9472):1718-26.
  • 8Law WL,Lee YM,Choi HK,et al.Laparoscopic and open anteriorresection for upper and mid rectal cancer:an evaluation of outcomes[J].Dis Colon Rectum,2006,49(8):1108-15.
  • 9Braga M,Frasson M,Vignali A,et al.Laparoscopic resection inrectal cancer patients:outcome and cost-benefit analysis[J].DisColon Rectum,2007,50(4):464-71.
  • 10Lelong B,Bege T,Esterni B,et al.Short-term outcome afterlaparoscopic or open restorative mesorectal excision for rectalcancer:a comparative cohort study[J].Dis Colon Rectum,2007,50(2):176-83.

二级参考文献48

  • 1Lacy AM,García-Valdecasas JC,Delgado S,et al.Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer:a randomised trial.Lancet,2002,359(9325):2224-2229.
  • 2Ng SS,Leung KL,Lee JF,et al.Laparoscopic-assisted versus open abdominoperineal resection for low rectal cancer:a prospective randomized trial.Ann Surg Oncol,2008,15(9):2418-2425.
  • 3Clinical Outcomes of Surgical Therapy Study Group.A comparison of laparoscopically assisted and open colectomy for colon cancer.N Engl J Med,2004,350(20):2050-2059.
  • 4Guillou PJ,Quirke P,Thorpe H,et al.Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer(MRC CLASICC trial):multicentre,randomised controlled trial.Lancet,2005,365(9472):1718-1726.
  • 5National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology:colon cancer.V.2.2011.http://www.nccn.org/professionals/physician_gls/pdf/colon.pdf.
  • 6National Comprehensive Cancer Network.NCCN Clinical Practice Guidelines in Oncology:rectal cancer.V.2.2011.http://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf.
  • 7Edge SB,Byrd DR,Compton CC,et al.AJCC Cancer Staging Manual.7th ed.New York:Springer,2010.
  • 8Van Custem E,Lang,I,Folprecht G,et al.Cetuximab plus FOLFIRI in the treatment of metastatic colorectal cancer (mCRC):The influence of KRAS and BRAF biomarkers on outcome:Updated data from the CRYSTAL trial.ASCOGastrointestinal Cancer Symposium,2010:abstract 281.
  • 9Di Nicolantonio F,Martini M,Molinari F,et al.Wild-type BRAF is required for response to panitumumab or cetuximab in metastatic colorectal cancer.J Clin Oncol,2008,26 (35):5705 -5712.
  • 10Bokmeyer C,Kohne C,Rougier C,et al.Cetuximab with chemotherapy as first-line treatment for metastatic colorectal cancer:Analysis of the CRYSTAL and OPUS studies according to KRAS and BRAF mutation analysis.J Clin Oncol,2010,28suppl 15:abstract 3506.

共引文献99

同被引文献285

引证文献32

二级引证文献231

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部